OncoGenex Adds New Chairman

3/24/10Follow @xconomy

OncoGenex Pharmaceuticals (NASDAQ: OGXI), the Bothell, WA-based developer of cancer drugs, said today it has named Jack Goldstein as its new chairman, and H. Stewart Parker as a member of its board of directors. Current board members Dwight Winstead and Michael Martino plan to step down at the company’s upcoming annual meeting on June 8. Goldstein was president and chief operating officer of Chiron when that company was acquired by Novartis in 2006, while Parker was the founder and CEO of Seattle-based Targeted Genetics until she left the company in November 2008.

By posting a comment, you agree to our terms and conditions.